Publication planning in the NYT

Wyeth has now been added to the list of pharmaceutical companies on which there are excellent documents showing how they hire ghostwriters to produce scientific papers to sell drugs. Cudos to the New York Times and PLoS Medicine. Now here’s me as a broken record: Unfortunately, this is not just a common activity: it is the norm. Read More...

Stossel's crusade for conflict of interest

From http://www.insidehighered.com/news/2009/07/10/acre)

Thomas Stossel, the American Cancer Society Professor of Medicine at Harvard Medical School, is spearheading a new nonprofit professional organization that is, according to Stossel's preliminary description, "to be a forum for what we believe is a hitherto silent majority of individuals engaged in clinical service, medical education and medical innovation ready to oppose a small but well organized and well-funded coterie responsible for an anti-industry movement.”

There’s nothing like those well-funded critics. Read More...